It is important to keep in mind that people taking GLP-1 medications may already be at risk of developing SIBO for other reasons
The initial phase focuses on helping you tolerate the dose while Semaglutide GLP-1 starts influencing appetite regulation and digestion
It is not an officially licensed obesity medication in the UK
doi: 10.1097/MD.0000000000026086 45 ZhangFChenZWuDTianLChenQYeYet al
M., Rosenstock, J., Tran, M
14,17 Pharmacists and clinicians should counsel patients on red-flag symptoms that require prompt evaluation, such as persistent or severe abdominal pain, intractable nausea or vomiting, abdominal distention, bloating lasting several days, or the presence of bloody stools